Research Topics
| Martin M MinerSummaryAffiliation: Brown University Country: USA Publications
| Collaborators |
Detail Information
Publications
Vardenafil in men with stable statin therapy and dyslipidemiaMartin Miner
Clinical Associate Professor of Family Medicine, Brown University School of Medicine, Swansea, MA, USA
J Sex Med 5:1455-67. 2008..Phosphodiesterase type-5 (PDE-5) inhibitors have previously been evaluated for their efficacy and safety in various clinical trials in men with erectile dysfunction (ED) with or without associated comorbidities...
Health care cost implications of sildenafil citrateMartin Miner
Swansea Health Center, Swansea, MA, USA
J Sex Med 1:141-9. 2004..e., obesity, nicotine addiction, and erectile dysfunction)...
Distinguishing premature ejaculation from other sexual function disordersMartin Miner
Department of Family Medicine, Warren Alpert School of Medicine, Brown University, and Men s Health Center, Miriam Hospital, Providence, RI 02906, USA
Postgrad Med 120:54-63. 2008..Therefore, the development of new pharmacologic treatments for PE is warranted...
Men's health in primary care: an emerging paradigm of sexual function and cardiometabolic riskMartin M Miner
Department of Family Medicine and Urology, The Men s Health Center, The Miriam Hospital, The Warren Alpert School of Medicine, Brown University, Providence, RI 02906, USA
Urol Clin North Am 39:1-23. 2012..Indeed, erectile dysfunction may now be thought of as a harbinger of cardiovascular clinical events and other systemic vascular diseases in some men...
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetesMartin Miner
Department of Family Medicine, Warren Alpert School of Medicine, Brown University, Providence, RI, USA
Am Heart J 164:21-8. 2012..Identification of ED, particularly in men <60 years old and those with diabetes, represents an important first step toward CVD risk detection and reduction...
Cardiometabolic risk and female sexual health: the Princeton III summaryMartin Miner
Men s Health Center, Department of Family Medicine and Urology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA
J Sex Med 9:641-51; quiz 652. 2012..The first two Princeton Consensus Conferences were focused on relationships between male sexual function and cardiovascular health, and development of contemporary clinical guidelines for dysfunction management...
Hypoactive sexual desire disorder in premenopausal women: case studiesMartin Miner
Miriam Hospital, Warren Alpert School of Medicine, Brown University, Providence, RI 02906, USA
Postgrad Med 124:94-103. 2012..This article gives an overview of HSDD in clinical practice and provides 3 case descriptions to illustrate the treatment of low sexual desire in women with diverse histories...
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)Rajib K Bhattacharya
University of Kansas Medical Center, 3901 Rainbow Blvd, MS2024, Kansas City, KS 66160, USA
BMC Endocr Disord 11:18. 2011..abstract:..
Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ?Martin M Miner
Men s Health Center, Miriam Hospital, Warren Alpert Medical School, Brown University, Providence, RI 02906, USA
Curr Urol Rep 10:254-60. 2009..In contrast, the use of nonselective alpha-blockerswas appreciably greater among men seeing PCPs than men seeing urologists...
Erectile dysfunction: a harbinger or consequence: does its detection lead to a window of curability?Martin M Miner
Men s Health Center, Miriam Hospital, 164 Summit Ave, Providence, RI 029906, USA
J Androl 32:125-34. 2011..Patients with ED can be classified into low-, intermediate-, and high-risk categories. A proposed algorithm can be used to direct the assessment of cardiometabolic risk in patients with ED...
Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to lessen caM M Miner
The Miriam Hospital, Warren Alpert School of Medicine, Brown University, Providence, RI, USA
Int J Clin Pract 64:1754-62. 2010....
Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiencyMartin M Miner
Miriam Hospital Men s Health Center, Warren Alpert School of Medicine, Brown University, Providence, RI 02906, USA
Postgrad Med 123:17-27. 2011..Testosterone deficiency (TD) is prevalent among men seeking medical attention and may be associated with other comorbidities...
Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practicesMartin Miner
Warren Alpert School of Medicine, Brown University, Providence, RI 02912, USA
Postgrad Med 120:130-53. 2008..If TRT is initiated, a patient's response and adverse events should be assessed every 3 to 6 months, and therapy adjusted accordingly...
Erectile dysfunction: a sentinel marker for cardiovascular disease in primary careMartin M Miner
Department of Family Medicine, Brown University School of Medicine, Providence, RI, USA
Cleve Clin J Med 74:S30-7. 2007....
Evolving issues in male hypogonadism: evaluation, management, and related comorbiditiesMartin M Miner
Department of Family Medicine, Brown University School of Medicine, Providence, RI, USA
Cleve Clin J Med 74:S38-46. 2007..A potential association of testosterone replacement therapy with prostate cancer is the biggest safety concern, so patient monitoring should include regular digital rectal examination and prostate-specific antigen tests...
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual functionMartin Miner
Brown University, Swansea Family Practice Group, Swansea, Massachusetts 02777, USA
Clin Ther 28:13-25. 2006..Men who present with symptomatic BPH and LUTS are at increased risk for sexual dysfunction, including erectile dysfunction (ED) and ejaculatory dysfunction (EjD)...
Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?M M Miner
Department of Family Medicine, Brown University School of Medicine, Providence, RI, USA
Int J Clin Pract 61:622-32. 2007..Larger, longer-term randomised studies are needed to fully establish the effects of testosterone replacement therapy...
Centrally acting mechanisms for the treatment of male sexual dysfunctionMartin M Miner
Division of Biology and Medicine, Department of Family Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA
Urol Clin North Am 34:483-96, v. 2007..Drugs available in Europe include apomorphine. This article focuses on the mechanism of centrally acting agents and reviews clinical data on potential new centrally acting drugs for men who have ED...
Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inhibitors and statinsMartin Miner
Men s Health Center, The Miriam Hospital, Warren Alpert School of Medicine, Brown University, Swansea, MA, USA
J Sex Med 5:1066-78. 2008..Both ED and hyperlipidemia/dyslipidemia are rising in prevalence with mounting evidence that these conditions are harbingers of cardiovascular disease...
Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin studyMartin M Miner
Brown University School of Medicine, Providence, RI, USA
J Sex Med 7:1937-47. 2010..Dyslipidemia occurs often in subjects with erectile dysfunction (ED), but there is little information about how this condition affects ED treatment responses...
Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS)Gary Blick
CIRCLE CARE Center, Norwalk, Connecticut 06851, USA
Pain Med 13:688-98. 2012..Data from the Testim Registry in the United States were analyzed to determine the efficacy of testosterone replacement therapy in opioid users vs nonusers...
Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus?S A M Khatana
Target Research Enhancement Program, Providence Veterans Affairs Medical Center, Providence, RI 02908, USA
Int J Impot Res 20:501-6. 2008..0% were significantly associated with change in IIEF-5 (P=0.01, P=0.01, P=0.04, respectively). These results suggest that improved blood pressure and glycemic control in men with diabetes may lead to an improvement in ED...
Treatment, management, and monitoring of established rheumatoid arthritisClifton O Bingham
Division of Rheumatology and Allergy, The Johns Hopkins University, Baltimore, MD, USA
J Fam Pract 56:S1-7; quiz S8. 2007
Office evaluation of male sexual dysfunctionAllen D Seftel
Department of Urology, Case Medical Center, Cleveland, OH, USA
Urol Clin North Am 34:463-82, v. 2007..This article provides the rationale for this global assessment paradigm...
